首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1547381

全球胎盘干细胞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Placental Stem Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球胎盘干细胞治疗市场需求预计将从2023年的21.1亿美元达到2032年近113.8亿美元的市场规模，2024-2032年研究期间的复合年增长率为20.62%。

胎盘干细胞疗法涉及使用源自胎盘的干细胞来治疗各种疾病。胎盘是多能干细胞的丰富来源，可以在分娩后非侵入性地收集。这些细胞有潜力发育成不同类型的细胞并具有免疫调节特性，使其适用于再生医学和免疫相关疗法。应用包括治疗血液疾病、神经系统疾病和组织损伤等疾病。与胚胎干细胞相比，它具有诸如减少伦理问题以及由于胎盘独特的免疫学特性而降低免疫排斥风险等优点。

市场动态

慢性和退化性疾病的日益普及推动了胎盘干细胞治疗市场的发展，对先进且有效的治疗方案产生了巨大的需求。胎盘干细胞因其分化成各种细胞类型的能力及其免疫调节特性而具有广泛的治疗潜力。此外，干细胞研究和再生医学的进步增强了对胎盘干细胞的理解和应用，推动了市场成长。与胚胎干细胞相比，胎盘干细胞采集的非侵入性和伦理上有利的性质有助于其日益被接受和利用。此外，增加对生物技术和医疗保健领域的投资支持胎盘干细胞疗法的开发和商业化。监管支持和建立健全的临床试验框架也促进了市场扩张。人们越来越认识到干细胞疗法的好处及其治疗从血液疾病到组织损伤等多种疾病的潜力，这正在推动需求。个人化医疗的日益增长的趋势，即根据患者个别需求量身定制治疗方案，进一步推动了胎盘干细胞治疗市场的发展。然而，伦理问题、监管障碍以及与临床试验和商业化相关的高成本可能会阻碍胎盘干细胞治疗市场在未来几年的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球胎盘干细胞治疗市场的各个细分市场进行了包容性评估。胎盘干细胞治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

胎盘干细胞治疗市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按申请

血液系统恶性肿瘤和疾病
先天性免疫缺乏症
代谢紊乱
神经系统疾病

按最终用户

医院和专科诊所
临床研究组织
院校及院校

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲胎盘干细胞治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。胎盘干细胞治疗市场的主要参与者包括 Lifebank Stem Cell Banking、Celularity Inc.、Americord Registration、Reelabs Pvt.。 Ltd.、Pluristem Therapeutics Inc.、Mesoblast Limited、ReNeuron Group Plc、Athersys Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：胎盘干细胞治疗公司的竞争格局

胎盘干细胞治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Lifebank Stem Cell Banking

公司概况
公司收入
产品
最新动态

Celularity Inc.

公司概况
公司收入
产品
最新动态

Americord Registry

公司概况
公司收入
产品
最新动态

Reelabs Pvt. Ltd.

公司概况
公司收入
产品
最新动态

Pluristem Therapeutics Inc.

公司概况
公司收入
产品
最新动态

Mesoblast Limited

公司概况
公司收入
产品
最新动态

ReNeuron Group Plc

公司概况
公司收入
产品
最新动态

Athersys Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215707

The global demand for Placental Stem Cell Therapy Market is presumed to reach the market size of nearly USD 11.38 Billion by 2032 from USD 2.11 Billion in 2023 with a CAGR of 20.62% under the study period 2024-2032.

Placental stem cell therapy involves using stem cells derived from the placenta to treat various medical conditions. The placenta, a rich source of multipotent stem cells, can be harvested non-invasively after childbirth. These cells have the potential to develop into different types of cells and possess immunomodulatory properties, making them suitable for regenerative medicine and immune-related therapies. Applications include treating conditions such as blood disorders, neurological diseases, and tissue injuries. It offers advantages like reduced ethical concerns compared to embryonic stem cells and a lower risk of immune rejection due to the placenta's unique immunological profile.

MARKET DYNAMICS

The placental stem cell therapy market is propelled by the increasing prevalence of chronic and degenerative diseases, creating a significant demand for advanced and effective treatment options. Placental stem cells offer promising therapeutic potential due to their capacity to differentiate into various cell types and their immunomodulatory properties. Additionally, advancements in stem cell research & regenerative medicine enhance the understanding and application of placental stem cells, driving market growth. Compared to embryonic stem cells, the non-invasive and ethically favorable nature of placental stem cell collection contributes to their growing acceptance and utilization. Furthermore, increasing investments in biotechnology and healthcare sectors support the development and commercialization of placental stem cell therapies. Regulatory support and the establishment of robust clinical trial frameworks are also facilitating market expansion. The rising awareness about the benefits of stem cell therapies and their potential to treat a wide range of conditions, from blood disorders to tissue injuries, is driving demand. The increasing trend of personalized medicine, where treatments are customized to individual patient needs, further propels the placental stem cell therapy market. However, ethical concerns, regulatory hurdles, and the high costs associated with clinical trials and commercialization may hinder the growth of the placental stem cell therapy market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Placental Stem Cell Therapy. The growth and trends of Placental Stem Cell Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Placental Stem Cell Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Hematologic Malignancies And Disorders
Congenital Inmunodeficiency Disorders
Metabolic Disorders
Neurological Disorders

By End User

Hospitals & Specialty Clinics
Clinical Research Organizations
Research Institutes & Academies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Placental Stem Cell Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Placental Stem Cell Therapy market include Lifebank Stem Cell Banking, Celularity Inc., Americord Registry, Reelabs Pvt. Ltd., Pluristem Therapeutics Inc., Mesoblast Limited, ReNeuron Group Plc, Athersys Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PLACENTAL STEM CELL THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By End User
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLACENTAL STEM CELL THERAPY MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Hematologic Malignancies And Disorders Historic and Forecast Sales By Regions
5.4. Congenital Inmunodeficiency Disorders Historic and Forecast Sales By Regions
5.5. Metabolic Disorders Historic and Forecast Sales By Regions
5.6. Neurological Disorders Historic and Forecast Sales By Regions

6. GLOBAL PLACENTAL STEM CELL THERAPY MARKET ANALYSIS BY END USER

6.1. Overview By End User
6.2. Historical and Forecast Data Analysis By End User
6.3. Hospitals & Specialty Clinics Historic and Forecast Sales By Regions
6.4. Clinical Research Organizations Historic and Forecast Sales By Regions
6.5. Research Institutes & Academies Historic and Forecast Sales By Regions

7. GLOBAL PLACENTAL STEM CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PLACENTAL STEM CELL THERAPY COMPANIES

8.1. Placental Stem Cell Therapy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF PLACENTAL STEM CELL THERAPY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Lifebank Stem Cell Banking
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Celularity Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Americord Registry
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Reelabs Pvt. Ltd.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Pluristem Therapeutics Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Mesoblast Limited
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. ReNeuron Group Plc
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Athersys Inc
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments